A. M. Miscio

Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application

M. de Tommaso, M. Delussi, M. Leone, 2019, Toxins.

Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors

L. Pani, B. Colombo, S. Sacco, 2022, International journal of environmental research and public health.

Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy

M. Copetti, A. Fontana, M. Leone, 2020, Neurological Sciences.

Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients

M. Filippi, B. Colombo, S. Sacco, 2021, Pain and Therapy.

OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study

B. Colombo, S. Sacco, F. Vernieri, 2022, Journal of Neurology.

Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study

M. Filippi, B. Colombo, S. Sacco, 2021, Pain and Therapy.

Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting

M. Copetti, A. Fontana, M. Leone, 2017, Neurological Sciences.

P025. Two-year follow-up with OnabotulinumtoxinA for chronic migraine: a real life evaluation of 113 patients

M. Copetti, M. Leone, A. M. Miscio, 2015, The Journal of Headache and Pain.